Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

$FDA grants accelerated approval to melphalan flufenamide for relapsed or refractory multiple myeloma$

FDA grants accelerated approval to melphalan flufenamide for relapsed or refractory multiple myeloma

Single cell sequencing opens new avenues for eradicating leukaemia at its source

Single cell sequencing opens new avenues for eradicating leukaemia at its source

CAR T-cell therapy generates lasting remissions in patients with multiple myeloma

CAR T-cell therapy generates lasting remissions in patients with multiple myeloma

Improving immunotherapies for blood cancers: real-time exploration in the tumour

Improving immunotherapies for blood cancers: real-time exploration in the tumour

Penn-developed CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma

Penn-developed CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma

New classification of leukaemia subtypes reveals potential of existing drugs

New classification of leukaemia subtypes reveals potential of existing drugs

Blood-clotting protein plays key role in central nervous system b-cell lymphoma

Blood-clotting protein plays key role in central nervous system b-cell lymphoma

A new strategy to destroy cancer cells using magnetic nanoparticles and fields

A new strategy to destroy cancer cells using magnetic nanoparticles and fields

Get a load of ZIF! Better delivery of cancer immunotherapy

Get a load of ZIF! Better delivery of cancer immunotherapy

Insight about tumour microenvironment could boost cancer immunotherapy

Insight about tumour microenvironment could boost cancer immunotherapy

More from ecancer